QIAGEN

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.

CEO

Jonathan M. Pratt

CEOJonathan M. Pratt

Employees

5,654

Employees5,654

Headquarters

Venlo, Limburg

HeadquartersVenlo, Limburg

Founded

1996

Founded1996

Employees

5,654

Employees5,654

QGEN Key Statistics

Market cap

8.93B

Market cap8.93B

Price-Earnings ratio

22.54

Price-Earnings ratio22.54

Dividend yield

0.79%

Dividend yield0.79%

Average volume

1.58M

Average volume1.58M

High today

$44.63

High today$44.63

Low today

$43.31

Low today$43.31

Open price

$44.30

Open price$44.30

Volume

1.66M

Volume1.66M

52 Week high

$57.82

52 Week high$57.82

52 Week low

$32.53

52 Week low$32.53

Stock Snapshot

As of today, QIAGEN(QGEN) shares are valued at $43.33. The company's market cap stands at 8.93B, with a P/E ratio of 22.54 and a dividend yield of 0.79%.

During the trading session on 2026-09-19, QIAGEN(QGEN) shares reached a daily high of $44.63 and a low of $43.31. At a current price of $43.33, the stock is +0.0% higher than the low and still -2.9% under the high.

Trading activity shows a volume of 1.66M, compared to an average daily volume of 1.58M.

The stock's 52-week range extends from a low of $32.53 to a high of $57.82.

QGEN News

TipRanks 11h

BlackRock Discloses 11.58% Capital Stake and 12.99% Voting Rights in Qiagen

Qiagen ( (QGEN) ) just unveiled an announcement. Qiagen disclosed that the Dutch financial regulator AFM has published a notification showing U.S. asset manage...

Investing.com 12h

Qiagen schedules shareholder vote on new CEO appointment - Investing.com

...

Simply Wall St 1d

Qiagen Could Be 2% Undervalued After QIAsymphony Launch And Outlook Reaffirmed

Qiagen (QGEN) has drawn fresh attention after launching its QIAsymphony Connect automation platform, securing regulatory clearances in the US and Europe while m...

Analyst ratings

59%

of 22 ratings

Buy

40.9%

Hold

59.1%

Sell

More QGEN News

TipRanks 2d

Qiagen attracts interest from KKR, Advent, TPG, Manager Magazin reports

Qiagen (QGEN) is attracting interest from multiple private equity firms, including KKR (KKR), EQT, Advent, TPG (TPG), and Bain Capital, with expectations that s...

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Thermo Fisher Scientific

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.